Come up with a name for your new list and we'll add to it:
Innovative Biologics raised a round of funding on July 22, 2008. Investors include
National Institutes of Health.
IBI has recently demonstrated that treatment of Bacillus anthracis infected mice with a combination of the antibiotic ciprofloxacin and partially purified antibodies against anthrax protective antigen…